Lilly’s oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity Eli Lilly and Company Eli Lilly’s obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval CNBC Lilly’s Obesity Pill Cut Body Weight by 11% in Key …
Read More »Tag Archives: orforglipron
Eli Lilly obesity pill orforglipron led to 12% weight loss
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Thursday said the highest dose of its daily obesity pill helped patients lose almost 12% of their body weight, or roughly 27 pounds, at 72 weeks in a late-stage trial, paving way …
Read More »